<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC7128205/figure_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption> Discovery of novel activities and follow-up development of broad-spectrum antiviral agents (BSAAs). Yellow shading indicates a process of discovery and development of safe-in-man BSAAs, for which pharmacokinetic (PK) properties in pre-clinical (animal model) and early clinical developmental phases (phase 0-IIa trials) are already available. Abbreviations: ESCs, human embryonic stem cells; iPSCs, human induced pluripotent stem cells (iPSCs). </caption>
 <div class="graphic"/>
 <p class="label">Figure 1</p>
</div>
